Full Text View
Tabular View
No Study Results Posted
Related Studies
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
This study is ongoing, but not recruiting participants.
Study NCT00492531   Information provided by National Institutes of Health Clinical Center (CC)
First Received: June 26, 2007   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Disease
Pulmonary Hypertension
Additional conditions recognized in this trial
Anemia, Sickle Cell
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Cardiovascular Diseases
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Sildenafil
Placebo
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services